throbber
Trials@uspto.gov
`571-272-7822
`
`
`
`
`
`
`
`Paper 31
`Entered: August 31, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`ACRUX DDS PTY LTD. & ACRUX LIMITED,
`Petitioner,
`
`v.
`KAKEN PHARMACEUTICAL CO., LTD. and VALEANT
`PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner and Licensee.
`
`Case IPR2017-00190
`Patent 7,214,506 B2
`
`
`
`
`
`
`
`
`
`
`Before ERICA A. FRANKLIN, SUSAN L. C. MITCHELL, and
`ROBERT A. POLLOCK Administrative Patent Judges.
`
`MITCHELL, Administrative Patent Judge.
`
`
`
`ORDER
`Stay of Reissue Application No. 15/405,171
`37 C.F.R. 42.3(a); 37 C.F.R. § 4.122(a)
`
`
`
`
`
`
`
`
`
`

`

`IPR2017-00190
`Patent 7,214,506 B2
`
`
`Before institution of the instant inter partes proceeding, Kaken
`Pharmaceutical Co., Ltd. and Valeant Pharmaceuticals International, Inc.
`(collectively, “Petitioner”) requested authorization to file a motion to stay
`Reissue Application No. 15/405,171 (“the ’171 Reissue Application”),
`which involves that patent at issue here, U.S. Patent No. 7,214,506 (“the
`’506 Patent”). Paper 11, 2. At that time, we agreed with Patent Owner that
`a motion for a stay of the reissue proceeding would be premature, but invited
`Petitioner to renew its request to file a motion to stay should an inter partes
`review be instituted. Id. at 3.
`On May 1, 2017, we instituted an inter partes review of claims 1 and
`2 of the ’506 Patent based on six grounds. Paper 12, 24. Petitioner renewed
`its request for authorization to file a motion for a stay, and we granted such
`authorization. Paper 16, 2. Petitioner filed its Motion to Stay Related
`Reissue Proceeding, which Patent Owner opposed. Papers 19, 21, 22. For
`the reasons stated below, the Board exercises its discretion to stay
`examination of the ’171 Reissue Application.
`DISCUSSION
`The Director has authority to stay a reissue proceeding pursuant to
`
`35 U.S.C. § 315(d), which provides:
`(d) MULTIPLE PROCEEDINGS.— Notwithstanding sections
`135(a), 251, and 252, and chapter 30, during the pendency of an
`inter partes review, if another proceeding or matter involving
`the patent is before the Office, the Director may determine the
`manner in which the inter partes review or other proceeding or
`matter may proceed, including providing for stay, transfer,
`consolidation, or termination of any such matter or proceeding.
`37 C.F.R. § 42.122 permits the Board to enter an order to effect a stay as
`follows:
`
`
`
`2
`
`

`

`IPR2017-00190
`Patent 7,214,506 B2
`
`
`(a) Multiple Proceedings. Where another matter involving the
`patent is before the Office, the Board may during the pendency
`of the inter partes review enter any appropriate order regarding
`the additional matter including providing for the stay, transfer,
`consolidation, or termination of any such matter.
`37 C.F.R. § 42.122(a); see also 37 C.F.R. § 42.3 (providing the Board
`authority to exercise exclusive jurisdiction within the Office over an
`involved application and patent during the proceeding).
`
`As Patent Owner correctly points out, ordinarily we will not stay a
`reissue application unless good cause is shown because reissue applications
`are accorded special status. See Bio-Rad Labs., Inc. v. GE Healthcare Bio-
`Sciences AB, Case IPR2015-01826, slip op. at 2–3 (PTAB April 8, 2016)
`(paper 18) (citing MPEP § 1442). In this case, however, Petitioner has
`shown good cause to stay the reissue application.
`
`A stay may be warranted to avoid duplicating efforts in the Office, to
`avoid potentially inconsistent results, or to simplify the issues in a reissue
`application. See Hewlett-Packard Co. v. MCM Portfolio LLC, Case, Case
`IPR2013-00217, slip op. at 2–3 (PTAB May 10, 2013) (paper 8). Here all
`three reasons support staying prosecution of the reissue application.
`
`As Petitioner points out and Patent Owner agrees, reissue claims 1 and
`2 are essentially identical to claims 1 and 2, respectively, of the ’506 patent
`at issue in this proceeding. Paper 19, 2; Paper 21, 2 (stating “[o]nly claims 1
`and 2 are substantively identical to the two claims at issue in this IPR).
`Proceeding with concurrent examination of the ’171 Reissue Application
`and this inter partes review would duplicate the efforts of the Office at least
`as to claims 1 and 2 involved in each proceeding and could potentially result
`in inconsistencies between the two proceedings. Also, any final written
`
`
`
`3
`
`

`

`IPR2017-00190
`Patent 7,214,506 B2
`
`decision in this inter partes review with respect to the patentability of the
`challenged claims may simplify the issues in the reissue application.1
`
`Based upon the facts presented in the instant proceeding and in the
`’171 Reissue Application, the Board exercises its discretion under 35 U.S.C.
`§ 315(d) and 37 C.F.R. § 42.122(a), and orders that examination of the ’171
`Reissue Application be stayed pending the termination or completion of the
`instant proceeding.
`
`ORDER
`
`It is
`
`ORDERED that examination of Reissue Application 15/405,171, filed
`
`on January 12, 2017, is stayed pursuant to 37 C.F.R. §§ 42.3 and 42.122
`pending the termination or completion of IPR2017-00190; and
`
`FURTHER ORDERED that any due dates in Reissue Application
`15/405,171 are tolled.
`
`
`
`
`
`
`
`1 In opposition to Petitioner’s good cause showing, Patent Owner focuses its
`argument on the 31 new claims of varying scope in the ’171 Reissue
`Application “that are not at issue in this IPR and which raise new issues of
`patentability not raised here.” Paper 21, 1. Because we find that the overlap
`between claims 1 and 2 of the ’506 Patent and the ’171 Reissue Application
`prompts us to exercise our discretion to stay examination of the ’171 Reissue
`Application, we need not analyze further the issues raised concerning
`whether claims 3–33 are patentably distinct from claims 1 and 2 of the ’506
`patent as resolution of these issues in favor of Patent Owner would not
`overcome the good cause shown for staying the ’171 Reissue Application.
`See Paper 19, 2–33; Paper 21, 2–5; Paper 22, 1–3.
`4
`
`
`
`

`

`IPR2017-00190
`Patent 7,214,506 B2
`
`
`For PETITIONER:
`
`E. Anthony Figg
`Aydin H. Harston
`ROTHWELL FIGG, ERNST & MANBECK, P.C.
`effig@rothwellfigg.com
`aharston@rothwellfigg.com
`
`
`For PATENT OWNER:
`
`John D. Livingstone
`Naoki Yoshida
`Anthony Hartmann
`FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP
`KakenIPR@finnegan.com
`naoki.yoshida@finnegan.com
`hartmana@finnegan.com
`
`Toan P. Vo
`VALEANT PHARMACEUTICALS NORTH AMERICA LLC
`Toan.vo@bausch.com
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket